Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 32

2.

High potential of escalating HIV transmission in a low prevalence setting in rural Tanzania.

Yahya-Malima KI, Matee MI, Evjen-Olsen B, Fylkesnes K.

BMC Public Health. 2007 Jun 9;7:103.

3.

Implementation of an antiretroviral access program for HIV-1-infected individuals in resource-limited settings: clinical results from 4 African countries.

Sow PS, Otieno LF, Bissagnene E, Kityo C, Bennink R, Clevenbergh P, Wit FW, Waalberg E, Rinke de Wit TF, Lange JM; Cohort Program to Evaluate Access to Antiretroviral Therapy and Education Project Team.

J Acquir Immune Defic Syndr. 2007 Mar 1;44(3):262-7.

PMID:
17146376
4.

Risk factors for high early mortality in patients on antiretroviral treatment in a rural district of Malawi.

Zachariah R, Fitzgerald M, Massaquoi M, Pasulani O, Arnould L, Makombe S, Harries AD.

AIDS. 2006 Nov 28;20(18):2355-60.

PMID:
17117022
5.
6.

Determinants of mortality and nondeath losses from an antiretroviral treatment service in South Africa: implications for program evaluation.

Lawn SD, Myer L, Harling G, Orrell C, Bekker LG, Wood R.

Clin Infect Dis. 2006 Sep 15;43(6):770-6. Epub 2006 Aug 8.

PMID:
16912954
7.

Rapid scale-up of antiretroviral therapy at primary care sites in Zambia: feasibility and early outcomes.

Stringer JS, Zulu I, Levy J, Stringer EM, Mwango A, Chi BH, Mtonga V, Reid S, Cantrell RA, Bulterys M, Saag MS, Marlink RG, Mwinga A, Ellerbrock TV, Sinkala M.

JAMA. 2006 Aug 16;296(7):782-93.

PMID:
16905784
8.

Mortality and causes of death in adults receiving highly active antiretroviral therapy in Senegal: a 7-year cohort study.

Etard JF, Ndiaye I, Thierry-Mieg M, Guèye NF, Guèye PM, Lanièce I, Dieng AB, Diouf A, Laurent C, Mboup S, Sow PS, Delaporte E.

AIDS. 2006 May 12;20(8):1181-9.

PMID:
16691070
9.

Scaling up of highly active antiretroviral therapy in a rural district of Malawi: an effectiveness assessment.

Ferradini L, Jeannin A, Pinoges L, Izopet J, Odhiambo D, Mankhambo L, Karungi G, Szumilin E, Balandine S, Fedida G, Carrieri MP, Spire B, Ford N, Tassie JM, Guerin PJ, Brasher C.

Lancet. 2006 Apr 22;367(9519):1335-42.

PMID:
16631912
10.

Antiretroviral therapy in a thousand patients with AIDS in Haiti.

Severe P, Leger P, Charles M, Noel F, Bonhomme G, Bois G, George E, Kenel-Pierre S, Wright PF, Gulick R, Johnson WD Jr, Pape JW, Fitzgerald DW.

N Engl J Med. 2005 Dec 1;353(22):2325-34.

11.
12.

Initial response to highly active antiretroviral therapy in HIV-1C-infected adults in a public sector treatment program in Botswana.

Wester CW, Kim S, Bussmann H, Avalos A, Ndwapi N, Peter TF, Gaolathe T, Mujugira A, Busang L, Vanderwarker C, Cardiello P, Johnson O, Thior I, Mazonde P, Moffat H, Essex M, Marlink R.

J Acquir Immune Defic Syndr. 2005 Nov 1;40(3):336-43.

PMID:
16249709
13.

Efficacy of antiretroviral therapy programs in resource-poor settings: a meta-analysis of the published literature.

Ivers LC, Kendrick D, Doucette K.

Clin Infect Dis. 2005 Jul 15;41(2):217-24. Epub 2005 May 27.

PMID:
15983918
14.

Nutrition and HIV in the international setting.

Wanke C.

Nutr Clin Care. 2005 Jan-Mar;8(1):44-8. Review.

PMID:
15850234
15.

Impact of highly active antiretroviral therapy on anemia and relationship between anemia and survival in a large cohort of HIV-infected women: Women's Interagency HIV Study.

Berhane K, Karim R, Cohen MH, Masri-Lavine L, Young M, Anastos K, Augenbraun M, Watts DH, Levine AM.

J Acquir Immune Defic Syndr. 2004 Oct 1;37(2):1245-52.

PMID:
15385731
16.

Outcomes after two years of providing antiretroviral treatment in Khayelitsha, South Africa.

Coetzee D, Hildebrand K, Boulle A, Maartens G, Louis F, Labatala V, Reuter H, Ntwana N, Goemaere E.

AIDS. 2004 Apr 9;18(6):887-95.

PMID:
15060436
17.

Weight loss and survival in HIV-positive patients in the era of highly active antiretroviral therapy.

Tang AM, Forrester J, Spiegelman D, Knox TA, Tchetgen E, Gorbach SL.

J Acquir Immune Defic Syndr. 2002 Oct 1;31(2):230-6.

PMID:
12394802
18.
19.

Prognosis of HIV-1-infected patients starting highly active antiretroviral therapy: a collaborative analysis of prospective studies.

Egger M, May M, Chêne G, Phillips AN, Ledergerber B, Dabis F, Costagliola D, D'Arminio Monforte A, de Wolf F, Reiss P, Lundgren JD, Justice AC, Staszewski S, Leport C, Hogg RS, Sabin CA, Gill MJ, Salzberger B, Sterne JA; ART Cohort Collaboration.

Lancet. 2002 Jul 13;360(9327):119-29. Erratum in: Lancet 2002 Oct 12;360(9340):1178.

PMID:
12126821
20.

Thrombocytopenia in HIV-infected drug users in the HAART era.

Burbano X, Miguez MJ, Lecusay R, Rodriguez A, Ruiz P, Morales G, Castillo G, Baum M, Shor-Posner G.

Platelets. 2001 Dec;12(8):456-61.

PMID:
11798394

Supplemental Content

Support Center